Informed Risk Assessment: Leveraging Preclinical Safety Intelligence to anticipate Clinical Adverse Events
Event date: 26.06.2024Join Clarivate on June 26th at 4 pm CEST to explore “Informed Risk Assessment: Leveraging Preclinical Safety Intelligence to anticipate Clinical Adverse Events.” Discover how OFF-X’s tools mitigate risks in drug development, focusing on Semagacestat, BTK inhibitors, and 4-1BB activators. Enhance patient safety and streamline your development process with valuable insights ???
Agenda:
1. Challenges the pharma industry continues to face today
2. How the safety intelligence tool OFF-X can help de-risk drug development
3. Drug – Semagacestat
4. Target – BTK inhibitors
5. Target- 4-1BB activators
6. Summary
7. Q&A